Metabolic Disease clinical trials at UCSF

3 in progress, 1 open to eligible people

Metabolic disease is when the body cannot make or use energy from food properly. UCSF is testing a new medicine in adults with X-linked hypophosphatemia, a rare condition that causes low phosphate and weak bones. This study is a first-in-human trial to check safety and effects.

Showing trials for

  • First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

    open to eligible people ages 18-65

    A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

    San Francisco, California and other locations

  • Encaleret Compared to Standard of Care in Participants With ADH1

    Sorry, in progress, not accepting new patients

    The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

    Oakland, California and other locations

  • ADH1 and ADH2 Disease Monitoring Study (DMS)

    Sorry, in progress, not accepting new patients

    A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.

    Oakland, California and other locations

Our lead scientists for Metabolic Disease research studies include .

Last updated: